Clinical care of the HIV-infected drug user
- PMID: 17502234
- PMCID: PMC2128697
- DOI: 10.1016/j.idc.2007.03.009
Clinical care of the HIV-infected drug user
Abstract
HIV/AIDS and chemical dependency, the latter often intertwined with mental illness, are complex, overlapping spheres that adversely influence each other and the overall clinical outcomes of the affected individual. Each disorder individually impact tens of millions of people adversely, with explosive epidemics described worldwide. This article addresses the adverse consequences of HIV/AIDS, drug injection, the secondary comorbidities of both, and the impact of immunosuppression on presentation of disease as well as approaches to managing the HIV-infected drug user.
Figures
References
-
- Bruce RD, Altice FL. Why treat three conditions when it is one patient? AIDS Read. 2003;13(8):378–9. - PubMed
-
- Altice F, Friedland GH. Epidemiology of HIV infection and AIDS: past, present, and future. Disease Management and Health Outcomes. 1997;1(6):304–22.
-
- Douaihy AB, Jou RJ, Gorske T, et al. Triple diagnosis: dual diagnosis and HIV disease, part 2. AIDS Reader. 2003;13(8):375–82. see comment. - PubMed
-
- Douaihy AB, Jou RJ, Gorske T, et al. Triple diagnosis: dual diagnosis and HIV disease, Part 1. AIDS Reader. 2003;13(7):331–2. - PubMed
-
- Risk behaviors for HIV transmission among intravenous-drug users not in drug treatment–United States, 1987–1989. MMWR Morb Mortal Wkly Rep. 1990;39(16):273–6. - PubMed
